Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Subodh Verma shares the results of a sub-analysis from the SELECT trial in patients who had a prior history of CABG.
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Michelle Kittleson, MD, PhD
Frederick Ruberg, MD
Frederick Ruberg, MD
Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
